Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1996 2
1999 3
2002 3
2003 1
2004 1
2005 3
2006 3
2007 3
2008 1
2009 5
2010 3
2011 4
2012 5
2013 3
2014 1
2015 10
2016 11
2017 12
2018 12
2019 12
2020 8
2021 11
2022 16
2023 11
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

122 results

Results by year

Filters applied: . Clear all
Page 1
Phase 3 Trial of Nemolizumab in Patients with Prurigo Nodularis.
Kwatra SG, Yosipovitch G, Legat FJ, Reich A, Paul C, Simon D, Naldi L, Lynde C, De Bruin-Weller MS, Nahm WK, Sauder M, Gharib R, Barbarot S, Szepietowski JC, Conrad C, Fleischer A, Laquer VT, Misery L, Serra-Baldrich E, Lapeere H, Ahmad F, Jabbar Lopez ZK, Piketty C, Ständer S; OLYMPIA 2 Investigators. Kwatra SG, et al. Among authors: de bruin weller ms. N Engl J Med. 2023 Oct 26;389(17):1579-1589. doi: 10.1056/NEJMoa2301333. N Engl J Med. 2023. PMID: 37888917 Clinical Trial.
Dupilumab-Associated Lymphoid Reactions in Patients With Atopic Dermatitis.
Boesjes CM, van der Gang LF, Bakker DS, Ten Cate TA, Spekhorst LS, de Graaf M, van Dijk MR, de Bruin-Weller MS. Boesjes CM, et al. Among authors: de bruin weller ms. JAMA Dermatol. 2023 Nov 1;159(11):1240-1247. doi: 10.1001/jamadermatol.2023.3849. JAMA Dermatol. 2023. PMID: 37851456
Dupilumab Drug Survival and Associated Predictors in Patients With Moderate to Severe Atopic Dermatitis: Long-term Results From the Daily Practice BioDay Registry.
Spekhorst LS, de Graaf M, Zuithoff NPA, van den Reek JMPA, Kamsteeg M, Boesjes CM, Romeijn GLE, Loman L, Haeck I, Oosting AJ, de Boer-Brand A, Touwslager WRH, Flinterman A, van Lynden-van Nes AMT, Gostynski AH, de Bruin-Weller MS, Schuttelaar ML. Spekhorst LS, et al. Among authors: de bruin weller ms. JAMA Dermatol. 2022 Sep 1;158(9):1048-1056. doi: 10.1001/jamadermatol.2022.3014. JAMA Dermatol. 2022. PMID: 35947364 Free PMC article.
Successful tapering of dupilumab in patients with atopic dermatitis with low disease activity: a large pragmatic daily practice study from the BioDay registry.
Spekhorst LS, Boesjes CM, Loman L, Zuithoff NPA, Bakker DS, Kamphuis E, Kamsteeg M, Haeck IM, Oosting AJ, van Lumig PPM, van Lynden-van Nes AMT, Tupker RA, Flinterman A, Garritsen FM, Touwslager WRH, de Bruin-Weller MS, Schuttelaar MA, de Graaf M. Spekhorst LS, et al. Among authors: de bruin weller ms. Br J Dermatol. 2023 Aug 24;189(3):327-335. doi: 10.1093/bjd/ljad159. Br J Dermatol. 2023. PMID: 37177895
Effectiveness of Upadacitinib in Patients with Atopic Dermatitis including those with Inadequate Response to Dupilumab and/or Baricitinib: Results from the BioDay Registry.
Boesjes CM, Van der Gang LF, Zuithoff NPA, Bakker DS, Spekhorst LS, Haeck I, Kamsteeg M, De Graaf M, De Bruin-Weller MS. Boesjes CM, et al. Among authors: de bruin weller ms. Acta Derm Venereol. 2023 Feb 16;103:adv00872. doi: 10.2340/actadv.v103.5243. Acta Derm Venereol. 2023. PMID: 36794894 Free PMC article.
Towards personalized treatment in atopic dermatitis.
van der Schaft J, Thijs JL, Garritsen FM, Balak D, de Bruin-Weller MS. van der Schaft J, et al. Among authors: de bruin weller ms. Expert Opin Biol Ther. 2019 May;19(5):469-476. doi: 10.1080/14712598.2019.1583204. Epub 2019 Feb 26. Expert Opin Biol Ther. 2019. PMID: 30768375 Review.
Current and Future Biomarkers in Atopic Dermatitis.
Thijs JL, de Bruin-Weller MS, Hijnen D. Thijs JL, et al. Among authors: de bruin weller ms. Immunol Allergy Clin North Am. 2017 Feb;37(1):51-61. doi: 10.1016/j.iac.2016.08.008. Epub 2016 Oct 28. Immunol Allergy Clin North Am. 2017. PMID: 27886910 Review.
122 results